Rocket Pharmaceuticals, Inc. (RCKT)

NASDAQ: RCKT · IEX Real-Time Price · USD

19.78

-0.88 (-4.26%)

At close: Jul 2, 2024, 4:00 PM

20.38

+0.60 (3.03%)

After-hours: Jul 2, 2024, 6:55 PM EDT

Rocket Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-245.6	-221.86	-169.07	-139.7	-77.27	Upgrade
Depreciation & Amortization	7.1	6.27	5.37	6.25	0.43	Upgrade
Share-Based Compensation	39.41	31.01	29.24	18.57	13.37	Upgrade
Other Operating Activities	4.18	6.45	13.3	40.24	-1.19	Upgrade
Operating Cash Flow	-194.92	-178.14	-121.16	-74.64	-64.66	Upgrade
Capital Expenditures	-16.47	-8.62	-7.72	-29.06	-23.27	Upgrade
Acquisitions	0	42.73	0	0	0	Upgrade
Change in Investments	-81.59	-103.43	26.57	-67.53	-15.74	Upgrade
Investing Cash Flow	-98.07	-69.33	18.85	-96.59	-39.01	Upgrade
Share Issuance / Repurchase	208.4	155.29	37.68	283.84	178.14	Upgrade
Debt Issued / Paid	0	0	0	-0.24	0	Upgrade
Other Financing Activities	-	-	-	-0.61	-0.34	Upgrade
Financing Cash Flow	208.4	155.29	37.68	282.99	177.79	Upgrade
Net Cash Flow	-84.58	-92.18	-64.63	111.76	74.12	Upgrade
Free Cash Flow	-211.39	-186.76	-128.88	-103.7	-87.93	Upgrade
Free Cash Flow Per Share	-2.52	-2.74	-2.04	-1.87	-1.79	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).